Menu
Currency
GWAS Study

Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis.

Terao C, Kawaguchi T, Dieude P et al.

28314753 PubMed ID
GWAS Study Type
19171 Participants
29 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TC
Terao C
KT
Kawaguchi T
DP
Dieude P
VJ
Varga J
KM
Kuwana M
HM
Hudson M
KY
Kawaguchi Y
MM
Matucci-Cerinic M
OK
Ohmura K
RG
Riemekasten G
KA
Kawasaki A
AP
Airo P
HT
Horita T
OA
Oka A
HE
Hachulla E
YH
Yoshifuji H
CP
Caramaschi P
HN
Hunzelmann N
BM
Baron M
AT
Atsumi T
HP
Hassoun P
TT
Torii T
TM
Takahashi M
TY
Tabara Y
SM
Shimizu M
TA
Tochimoto A
AN
Ayuzawa N
YH
Yanagida H
FH
Furukawa H
TS
Tohma S
HM
Hasegawa M
FM
Fujimoto M
IO
Ishikawa O
YT
Yamamoto T
GD
Goto D
AY
Asano Y
JM
Jinnin M
EH
Endo H
TH
Takahashi H
TK
Takehara K
SS
Sato S
IH
Ihn H
RS
Raychaudhuri S
LK
Liao K
GP
Gregersen P
TN
Tsuchiya N
RV
Riccieri V
MI
Melchers I
VG
Valentini G
CA
Cauvet A
MM
Martinez M
MT
Mimori T
MF
Matsuda F
AY
Allanore Y
Chapter II

Abstract

Summary of the research findings

Objectives: Systemic sclerosis (SSc) is an autoimmune disease characterised by skin and systemic fibrosis culminating in organ damage. Previous genetic studies including genome-wide association studies (GWAS) have identified 12 susceptibility loci satisfying genome-wide significance. Transethnic meta-analyses have successfully expanded the list of susceptibility genes and deepened biological insights for other autoimmune diseases.

700 Japanese ancestry cases, 1,797 Japanese ancestry controls, 564 European ancestry cases, 1,776 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

19171
Total Participants
GWAS
Study Type
Yes
Replicated
564 Japanese ancestry cases, 1,863 Japanese ancestry controls, 2,592 European ancestry cases, 9,315 European ancestry controls
Replication Participants
East Asian, European
Ancestry
Japan, France, Canada, U.S., Germany, Italy
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.